Yoshihiro Eriguchi

2.2k total citations
21 papers, 508 citations indexed

About

Yoshihiro Eriguchi is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Yoshihiro Eriguchi has authored 21 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Yoshihiro Eriguchi's work include Antifungal resistance and susceptibility (4 papers), Antimicrobial Peptides and Activities (4 papers) and Fungal Infections and Studies (3 papers). Yoshihiro Eriguchi is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Antimicrobial Peptides and Activities (4 papers) and Fungal Infections and Studies (3 papers). Yoshihiro Eriguchi collaborates with scholars based in Japan, United States and Vietnam. Yoshihiro Eriguchi's co-authors include Takanori Teshima, Kiminori Nakamura, Tokiyoshi Ayabe, Nobuyuki Shimono, Koichi Akashi, Shinji Shimoda, Sonoko Shimoji, Hiromi Iwasaki, Hidetaka Uryu and Shuichiro Takashima and has published in prestigious journals such as Blood, Scientific Reports and Infection and Immunity.

In The Last Decade

Yoshihiro Eriguchi

20 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiro Eriguchi Japan 11 219 147 115 110 110 21 508
Renyong Guo China 13 265 1.2× 39 0.3× 99 0.9× 97 0.9× 82 0.7× 24 635
Eduard Ling Israel 11 182 0.8× 46 0.3× 159 1.4× 49 0.4× 54 0.5× 31 572
K Herrlinger Germany 7 250 1.1× 44 0.3× 300 2.6× 56 0.5× 77 0.7× 16 883
Karen E. Drysdale Australia 8 67 0.3× 135 0.9× 228 2.0× 53 0.5× 101 0.9× 8 557
Yanfang Lu China 17 279 1.3× 25 0.2× 272 2.4× 110 1.0× 141 1.3× 30 832
Jyotsna Agarwal India 12 145 0.7× 36 0.2× 41 0.4× 33 0.3× 115 1.0× 37 548
Barbara Glanemann United Kingdom 12 97 0.4× 102 0.7× 42 0.4× 18 0.2× 62 0.6× 37 432
Carole Nagant Belgium 15 286 1.3× 52 0.4× 84 0.7× 14 0.1× 197 1.8× 30 589
A. B. Rogers United States 12 279 1.3× 21 0.1× 137 1.2× 97 0.9× 102 0.9× 14 752
Mark H. T. Stappers Netherlands 14 113 0.5× 31 0.2× 214 1.9× 31 0.3× 158 1.4× 24 521

Countries citing papers authored by Yoshihiro Eriguchi

Since Specialization
Citations

This map shows the geographic impact of Yoshihiro Eriguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Eriguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Eriguchi more than expected).

Fields of papers citing papers by Yoshihiro Eriguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Eriguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Eriguchi. The network helps show where Yoshihiro Eriguchi may publish in the future.

Co-authorship network of co-authors of Yoshihiro Eriguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Eriguchi. A scholar is included among the top collaborators of Yoshihiro Eriguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Eriguchi. Yoshihiro Eriguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakamura, Keiji, et al.. (2024). Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications. BMC Infectious Diseases. 24(1). 736–736. 4 indexed citations
3.
Eriguchi, Yoshihiro, Noriko Miyake, Yoji Nagasaki, et al.. (2023). Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020. Medical Mycology. 61(6). 4 indexed citations
4.
Eriguchi, Yoshihiro, Tomonori Sato, Akiko Yonekawa, et al.. (2023). Platypnea-Orthodeoxia Syndrome in Coronavirus Disease 2019 Pneumonia: A Case Report and Literature Review. International Medical Case Reports Journal. Volume 16. 201–207. 2 indexed citations
5.
Lai, Keane K. Y., Cu Nguyen, David Pei‐Cheng Lin, et al.. (2021). p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair. Cancers. 13(6). 1288–1288. 11 indexed citations
6.
Schaal, Justin B., Yoshihiro Eriguchi, Dat Q. Tran, et al.. (2021). A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections. Scientific Reports. 11(1). 23447–23447. 5 indexed citations
7.
Chong, Yong, Hideyuki Ikematsu, Naoki Tani, et al.. (2020). Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients. Influenza and Other Respiratory Viruses. 15(1). 13–18. 5 indexed citations
8.
Tran, Dat Q., Justin B. Schaal, Patti Tran, et al.. (2019). Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms. Scientific Reports. 9(1). 16905–16905. 16 indexed citations
9.
Eriguchi, Yoshihiro, Kiminori Nakamura, Yuki Yokoi, et al.. (2018). Essential role of IFN-γ in T cell–associated intestinal inflammation. JCI Insight. 3(18). 74 indexed citations
10.
Cobo, Eduardo R., France Moreau, Kiminori Nakamura, et al.. (2018). Entamoeba histolytica Alters Ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infection and Immunity. 86(7). 10 indexed citations
11.
Eriguchi, Yoshihiro, Kiminori Nakamura, Daigo Hashimoto, et al.. (2015). Decreased secretion of Paneth cell α‐defensins in graft‐versus‐host disease. Transplant Infectious Disease. 17(5). 702–706. 43 indexed citations
12.
Shimoji, Sonoko, Kumiko Kato, Yoshihiro Eriguchi, et al.. (2013). Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Bone Marrow Transplantation. 48(9). 1249–1252. 15 indexed citations
13.
Eriguchi, Yoshihiro, Hidetaka Uryu, Kiminori Nakamura, et al.. (2013). Reciprocal Expression of Enteric Antimicrobial Proteins in Intestinal Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 19(10). 1525–1529. 15 indexed citations
14.
Eriguchi, Yoshihiro, Shuichiro Takashima, Sonoko Shimoji, et al.. (2012). Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood. 120(1). 223–231. 230 indexed citations
15.
Miyake, Noriko, Yoriko Sato, Yoshihiro Eriguchi, et al.. (2011). [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].. PubMed. 64(4). 231–7. 3 indexed citations
16.
Uchida, Yujiro, et al.. (2010). Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. International Journal of Antimicrobial Agents. 35(5). 444–450. 25 indexed citations
17.
Nagasaki, Yoji, Yoshihiro Eriguchi, Noriko Miyake, et al.. (2010). Hematological Unit Invasive Aspergillosis Epidemiology. Kansenshogaku zasshi. 84(2). 176–181. 6 indexed citations
18.
Nagasaki, Yoji, Yoshihiro Eriguchi, Yukiko Uchida, et al.. (2009). Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model. Journal of Antimicrobial Chemotherapy. 64(2). 379–382. 17 indexed citations
19.
Uchida, Yujiro, et al.. (2007). Combined antibacterial effects of between meropenem and vancomycin, teicoplanin, linezolid, or arbekacin in methicillin-resistant Staphylococcus aureus. 55(5). 363–367. 2 indexed citations
20.
Eriguchi, Yoshihiro, Seiji Tsunada, Sadahiro Amemori, et al.. (2006). [A case of relapsed ischemic colitis with colon cast-like stripped mucosa].. PubMed. 103(10). 1152–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renyong Guo Breakdown of academic impact, for papers by Eduard Ling Breakdown of academic impact, for papers by K Herrlinger Breakdown of academic impact, for papers by Karen E. Drysdale Breakdown of academic impact, for papers by Yanfang Lu Breakdown of academic impact, for papers by Jyotsna Agarwal Breakdown of academic impact, for papers by Barbara Glanemann Breakdown of academic impact, for papers by Carole Nagant Breakdown of academic impact, for papers by A. B. Rogers Breakdown of academic impact, for papers by Mark H. T. Stappers
Rankless by CCL
2026